当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析

东诚药业

(002675)

  

流通市值:93.74亿  总市值:103.98亿
流通股本:7.43亿   总股本:8.25亿

东诚药业(002675)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.35亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益540440.72万元,未分配利润152966.66万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产917896.78万元,负债377456.06万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入626,367,330.362,741,074,183.832,043,088,592.831,383,711,882.86
营业总成本577,283,980.832,521,698,364.081,862,700,437.321,268,737,113.89
其他经营收益
营业利润48,584,595.09212,638,764.73182,448,575.03113,615,043.19
利润总额48,406,137.03211,442,575.58181,665,295.6112,088,452.64
净利润34,867,172.49154,441,271.11124,555,089.7870,039,313.7
每股收益
其他综合收益-15,147,336.34-566,212.92-1,998,026.561,813,407.68
综合收益总额19,719,836.15153,875,058.19122,557,063.2271,852,721.38
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,613,889,566.472,684,935,912.332,878,878,277.842,647,358,901.9
非流动资产:
非流动资产合计6,565,078,218.596,538,825,863.816,406,478,615.436,308,154,947.63
资产总计9,178,967,785.069,223,761,776.149,285,356,893.278,955,513,849.53
流动负债:
流动负债合计1,531,092,539.691,636,007,566.041,686,474,175.841,607,074,426.45
非流动负债:
非流动负债合计2,243,468,084.682,124,049,223.472,153,452,623.161,893,070,205.72
负债合计3,774,560,624.373,760,056,789.513,839,926,7993,500,144,632.17
所有者权益(或股东权益):
归属于母公司股东权益合计4,286,341,387.784,350,054,961.754,373,160,161.174,487,629,570.58
股东权益合计5,404,407,160.695,463,704,986.635,445,430,094.275,455,369,217.36
负债和股东权益合计9,178,967,785.069,223,761,776.149,285,356,893.278,955,513,849.53
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计628,686,385.292,879,154,143.362,202,991,434.511,492,531,673.66
经营活动现金流出小计660,084,916.822,299,303,748.91,861,997,106.941,224,925,398.61
经营活动产生的现金流量净额-31,398,531.53579,850,394.46340,994,327.57267,606,275.05
投资活动产生的现金流量:
投资活动现金流入小计262,343,044.371,151,461,823.44897,898,457.79529,090,730.07
投资活动现金流出小计282,296,959.111,706,136,211.221,248,820,265.77831,893,464.33
投资活动产生的现金流量净额-19,953,914.74-554,674,387.78-350,921,807.98-302,802,734.26
筹资活动产生的现金流量:
筹资活动现金流入小计161,889,298.6928,226,113.98914,557,566.61632,959,214.02
筹资活动现金流出小计161,923,441.83841,905,373.98685,673,135.37629,162,421.71
筹资活动产生的现金流量净额-34,143.2386,320,740228,884,431.243,796,792.31
汇率变动对现金及现金等价物的影响-2,501,209.53-2,391,921.442,482,833.66,625,400.82
现金及现金等价物净增加额-53,887,799.03109,104,825.24221,439,784.43-24,774,266.08
期末现金及现金等价物余额793,191,007.2844,725,390.32957,060,349.51710,846,299
补充资料:
现金及现金等价物的净增加额-109,104,825.24--24,774,266.08
最新报告期:2026-05-12
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券宋硕,陈竹,曾令鹏0.360.500.562026-05-12
野村东方国际证券孔令岩0.300.370.422026-05-07
光大证券吴佳青0.270.340.442026-05-02
西部证券李梦园0.390.440.502026-04-02
东吴证券刘若彤,朱国广0.300.410.512026-04-02
TOP↑